Association of calcium antagonist use with lower hemoglobin levels in hemodialysis patients

Abstract

Aim. Objective of the present study was to investigate whether calcium antagonist use is associated with lower hemoglobin levels and/or higher erythropoiesis stimulating agent (ESA) requirement in hemodialysis patients.